HOLX

Hologic, Inc.
Inactive Not actively trading
$76.01
+0.00 (+0.00%)
Mkt Cap 16.97B
Volume 101,956,189
52W Range 51.9-76.07
Sector Healthcare
Beta 0.70
EPS (TTM) 2.43
P/E Ratio 31.28
Revenue (TTM) 4.13B
Rev Growth (5Y) +3.3%
EPS Growth (5Y) +8.7%
AlphaVal · Fair Value
What we estimate one share is worth
$60.97
Overvalued moderate signal
24.7% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
65.4 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 4.10B 4.03B 4.03B 4.86B 5.63B 3.78B 3.37B 3.22B 3.06B 2.83B 2.71B 2.53B
Net Income 565.70M 789.50M 456.00M 1.30B 1.87B 1.12B (40.20M) (111.30M) 755.50M 330.80M 131.60M 17.30M
EPS 2.50 3.35 1.85 5.18 7.28 4.24 -0.15 -0.40 2.70 1.18 0.47 0.06
Free Cash Flow 920.10M 1.15B 901.00M 2.00B 2.15B 740.20M 535.90M 627.30M (99.30M) 688.70M 696.70M 428.20M
FCF / Share 4.05 4.86 3.65 7.95 8.37 2.82 1.99 2.28 -0.35 2.46 2.48 1.55
Operating CF 1.06B 1.29B 1.05B 2.13B 2.33B 896.60M 649.50M 732.90M 8.30M 787.20M 786.10M 508.40M
Total Assets 9.01B 9.16B 9.14B 9.07B 8.92B 7.20B 6.61B 7.23B 7.98B 7.32B 7.67B 8.41B
Total Debt 2.63B 2.66B 2.90B 2.92B 3.14B 3.15B 3.11B 3.36B 3.38B 3.38B 3.65B 4.30B
Cash & Equiv 1.96B 2.16B 2.72B 2.34B 1.17B 701.00M 601.80M 666.70M 540.60M 548.40M 492.70M 741.60M
Book Value 5.05B 5.13B 5.02B 4.88B 4.22B 2.71B 2.28B 2.43B 2.78B 2.14B 2.08B 2.06B
Return on Equity 0.11 0.15 0.09 0.27 0.44 0.41 -0.02 -0.05 0.27 0.15 0.06 0.01
HOLX News
Blackstone, TPG seek over $4 billion for Hologic's surgical unit, FT says
Jul 08, 2026 09:22 PM · reuters.com
Hologic's New Sustainability Report Marks 40 Years of Impact
Jun 17, 2026 05:00 AM · businesswire.com
Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology
Jun 16, 2026 09:00 AM · businesswire.com
OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic's Aptima HPV Assay
May 11, 2026 04:00 AM · businesswire.com
New Evidence Backs Hologic's AI-Powered Mammography Technology for Detecting Challenging Cancers
Apr 20, 2026 04:05 AM · businesswire.com
Blackstone and TPG Complete Acquisition of Hologic
Apr 07, 2026 05:10 AM · businesswire.com
Hologic Target of Unusually Large Options Trading (NASDAQ:HOLX)
Apr 06, 2026 09:25 PM · defenseworld.net
Casey's General Stores Set to Join S&P 500; DigitalOcean Holdings to Join S&P MidCap 400; Broadstone Net Lease to Join S&P SmallCap 600
Apr 06, 2026 01:51 PM · prnewswire.com
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
Apr 06, 2026 04:00 AM · businesswire.com
Exchange Traded Concepts LLC Lowers Position in Hologic, Inc. $HOLX
Apr 03, 2026 11:52 PM · defenseworld.net